Vitamin B6 for mood side effects of levetiracetam in people with brain tumors
Official title: B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is testing whether a daily vitamin B6 supplement helps with mood side effects from a seizure medicine.
Read our full plain-language summary
What the trial team says
This is a supportive care study to assess the effect of Vitamin B6 supplementation on mood-related side effects of levetiracetam in patients with brain tumors, who have already been prescribed levetiracetam for the prevention of seizures. This study will assess this effect from the perspective of both the patient and the patient's caregiver. Patients will receive Vitamin B6 as a supplement to take daily for 8 to 12 weeks, in addition to the already prescribed levetiracetam and will undergo study assessments as well as complete self-reported questionnaires to evaluate their mood during the course of the study. Additionally, each patient will be asked to optionally identify a designated caregiver, who will complete questionnaires assessing the patient's mood changes, at the same time interval as the patient.
Key facts
- Registry number
- NCT07271966
- Stage of testing
- Not applicable
- Conditions studied
- Brain Tumor Related Epilepsy (BTRE)
Where it is running
This trial lists 1 site.
-
North Carolina
- Duke University Medical Center (Durham)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.